Previous reviews have detailed the development of cellular therapies using immunologically nonspecific lymphokine activated killer cells (LAK), activated killer monocytes (AKM), and eventually tumor specific tumor infiltrating lymphocytes (TIL). The innovations in large scale cell culture methodologies and the developments in immune assessment approaches have made the therapies more widespread as well as more effective against a variety of tumor histologies.
|Title of host publication||Principles of Cancer Biotherapy|
|Subtitle of host publication||5th Edition|
|Number of pages||22|
|State||Published - 2009|
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology (all)